DIN 02505843 — SANDOZ TERIFLUNOMIDE 14 MG
SANDOZ TERIFLUNOMIDE is a tablet of Teriflunomide marketed by SANDOZ CANADA INCORPORATED. The full Teriflunomide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02505843
- Brand name
- SANDOZ TERIFLUNOMIDE
- Active ingredient
- Teriflunomide
- Strength
- 14 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Immunomodulator (pyrimidine synthesis inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Teriflunomide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02500639 | APO-TERIFLUNOMIDE | 14 MG | TABLET | APOTEX INC | MARKETED |
| 02504170 | JAMP TERIFLUNOMIDE | 14 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02523833 | M-TERIFLUNOMIDE | 14 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02500310 | NAT-TERIFLUNOMIDE | 14 MG | TABLET | NATCO PHARMA (CANADA) INC | MARKETED |
| 02500434 | PMS-TERIFLUNOMIDE | 14 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02501090 | TEVA-TERIFLUNOMIDE | 14 MG | TABLET | TEVA CANADA LIMITED | MARKETED |